Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title Comprehensive commissioning and quality assurance validation of Ethos? therapy
Creator Morel et al.
Author A. Morel
Author J. Prunaretty
Author D. Trauchessec
Author N. Ailleres
Author P. Fenoglietto
Author D. Azria
Abstract PURPOSE: Adaptive radiotherapy with the Ethos® therapy Varian system has been recently implemented at the Montpellier Cancer Institute, France. This article details the commissioning performed before the implementation of this new treatment planning system (TPS). MATERIAL AND METHODS: To validate the golden beam data of the machine (Halcyon linear accelerator), percentage depth doses (PDD) and profiles were measured for several field sizes and at different depths with a microdiamond chamber. The final doses calculated for different plan types with the Ethos Acuros XB algorithm and the Halcyon Eclipse Analytic Anisotropic Algorithm were compared using the gamma index method. Lastly, for the patient quality assurance (QA) process, the patient treatment plan results obtained with the Mobius3D QA platform (Varian) were compared with the portal dosimetry results obtained with Epiqa (Epidos). RESULTS: Minor differences were observed for the PDD and profile curves (mean difference of 0.2% and 2%, respectively). The ? index pass rate was above 98% for all measures using the 1%/1mm and 2%/2mm criteria for PDD and profile evaluations. The Ethos AXB algorithm was validated for every configuration (fixed fields, standard IMRT and VMAT fields, and clinical plans) with 2D/3D gamma index values>99%. Seventy-three 3-arcs-VMAT QA plans and 27 9-fields-IMRT QA plans were evaluated. Both showed excellent agreement with the TPS calculations (mean gamma pass rate higher than 99%). No difference was observed between IMRT and VMAT. CONCLUSION: The beam delivery, the Ethos AXB algorithm, and the patient QA were comprehensively validated using independent tools.
Publication Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique
Volume 27
Issue 5
Pages 355-361
Date 2023-09
Journal Abbr Cancer Radiother
Language eng
DOI 10.1016/j.canrad.2022.10.001
ISSN 1769-6658
Library Catalog PubMed
Extra Number: 5 PMID: 37085341
Tags Algorithms, Assurance qualité, clinic, Ethos?, first-last-coresponding, Humans, last, Particle Accelerators, QA validation, Radiometry, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Intensity-Modulated
Date Added 2023/11/23 - 12:48:20
Date Modified 2024/12/15 - 03:54:53
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés